Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy

Brain Research

Volumn 638, Issue 1-2, 1994, Pages 36-44

  Namba, Tazuko ^a   Morimoto, Kiyoshi ^a   Sato, Keiko ^b   Yamada, Norihito ^a   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

AMPA receptor; Amygdala; Anticonvulsant effect; Antiepileptogenic effect; Epilepsy; Hippocampus; Kindling; NBQX

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; ANTICONVULSIVE AGENT; GLUTAMATE RECEPTOR ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EPILEPSY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYGDALA; ANIMAL; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HIPPOCAMPUS; KINDLING (NEUROLOGY); QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0028054910     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(94)90630-0     Document Type: Article

References (40)

1. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats
2. The anticonvulsant effect of the non-NMDA antagonist, NBQX and GYKI 52466, mice
3. Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway in the rat hippocampus
4. Excitatory amino acid receptors in the vertebrate central nervous system
5. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis
6. Regional cerebral protein synthesis after transient ischemia in the rat: effect of the AMPA antagonist NBQX
7. The epileptiform activity induced by 4-aminopyridine in rat amygdala slices: antagonism by non-N-methyl-d-aspartate receptor antagonists
8. NMDA receptor-independent epileptiform activity induced by magnesium-free solution in rat amygdala neurons is blocked CNQX
9. The neuroprotective actions of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline (NBQX) in rat focal ischemia model
10. ong-term potentiation in the hippocampus involves activation in N-methyl-d-aspartate receptors
11. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition
12. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists
13. Blockade of ‘NMDA’ receptors disrupts experience-dependent platicity of kitten striate cortex
14. The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys
15. Involvement of non-NMDA receptors in picrotoxin-induced epileptiform activity in the hippocampus
16. NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons involves calcium influx via different routes
17. NMDA receptor activation and early olfactory learning
18. Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroschok models
19. The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system
20. Kindling-induced changes in EEG recorded during the stimulation from the site of stimulation: collapse of GABA-mediated inhibition and onset of rhythmic synchronous burst
21. Kindling-induced changes in EEG recorded during stimulation from the site of stimulation. III. Direct pharmacological manipulations of the kindled amygdala
22. Seizure-triggering mechanism in the kindling model of epilepsy:Collapse of GABA-mediated inhibition and activation of NMDA receptors
23. Effects of competitive NMDA receptor antagonists on kindling and LTP
24. Selective impairment of learning and blockade of long-term potentiation by a N-methyl-d-aspartate receptor antagonist, AP5
25. Antiepileptogenic action of 7-chlorokyurenic acid on amygdala-kindling of rats
26. Antagonism of spontaneous and evoked bursts by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) in the CA3 region of the in vivo hippocampus
27. Modification of seizure activity by electrical stimulation. II. Motor seizure
28. 3H]AMPA, a structural analogue of glutamic acid
29. Excitatory transmission in the basolateral amygdala
30. Kindling-induced long-lasting changes in synaptic transmission in the basolateral amygdala
31. Anticonvulsant action of a non-cometitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy
32. 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)-quinoxaline: a neuroprotectant for cerebral ischemia
33. The contribution of non-NMDA and NMDA receptors to graded bursting activity in the CA1 region of the hippocampus in a chronic model of epilepsy
34. The non-N-methyl-d-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy
35. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model
36. Binocular impulse blockade prevents the formation of ocular dominance columns in the cat visual cortex
37. Probenesid pretreatment enhances anticonvulsant action of NBQX in mice
38. NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-car☐y-piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats
39. Excitatory amino acid transmitters
40. NBQX, an AMPA antagonist, reduces glutamate-mediated brain edema